​Hims & Hers stock unravels as pricing fears and insider selling derail momentum The telehealth company Hims & Hers experienced a jarring reversal Friday as investor confidence evaporated following a combination of policy headwinds and executive share sales. After surging above $65 midweek on the company’s new menopause and perimenopause service launch, the stock plummeted […] The post $11 million insider sale shakes Hims & Hers confidence appeared first on Rolling Out.